If Walmart (NYSE: WMT) wrapped up its fiscal year with strong comps in the U.S., why did the stock fall 6%? What should you do when the company you own shares of is bought by another company? In this episode of MarketFoolery , host Chris Hill and analyst Jim Gillies analyze those questions and introduce Medpace Holdings (NASDAQ: MEDP) , a clinical research business more investors should know about.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our quick-start guide to investing in stocks . A full transcript follows the video.
For further details see:
A 4-Minute Look at Medpace Holdings